Clinical Trials in Phoenix

Showing 10301-10320 of 12,606 trials

Safety and Efficacy Study of a Single Dose of NA-1 in Patients Undergoing Endovascular Repair of Ruptured Aneurysms

NCT02056574

This is a randomized, double-blind, placebo-controlled, single-dose study investigating the safety and efficacy of NA-1 in patients with subarachnoid hemorrhage (SAH) undergoing endovascular repair of ruptured intracranial aneurysms. Up to 300 male and female patients with SAH undergoing endovascular repair of a ruptured intracranial aneurysm will be dosed with 2.60 mg/kg of NA-1 or placebo as a 10 minute intravenous infusion after completion of the endovascular procedure on Day 1 of the study period. Subjects will undergo interim procedures at Day 2-4, Day 30-45, and end-of-study procedures on Day 90.

Subarachnoid HemorrhageRuptured Intracranial Aneurysm

NoNO Inc.Started Nov 2015

Phoenix, Arizona, United States • Englewood, Colorado, United States • Ann Arbor, Michigan, United States +9 more locations

UNKNOWNPhase 1/2< 1 mile

Determining the Safety of L-serine in ALS

NCT01835782

The purpose of this study is to determine the safety of L-Serine in subjects with Amyotrophic Lateral Sclerosis (ALS) at varied doses.

Amyotrophic Lateral Sclerosis (ALS)

Phoenix Neurological Associates, LTD20 participantsStarted Jan 2013

Phoenix, Arizona, United States • San Francisco, California, United States

Safety and Efficacy Study of a Single Dose of NA-1 in Patients Undergoing Endovascular Repair of Ruptured Aneurysms

Determining the Safety of L-serine in ALS

Find Trials by Condition in Phoenix

SynCardia Freedom Driver System Study

Thyroid Dysfunction in Women With Newly Diagnosed Breast Cancer Compared to Healthy Volunteers

Patient Experience Study of Deoxycholic Acid Injection

A Study of RoActemra/Actemra (Tocilizumab) Given Subcutaneously in Combination With Traditional DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis

Study of Low Level Laser Light Therapy to Improve Blood Circulation in People With Chronic Heel Pain

Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer

A 16 Weeks Study on Efficacy and Safety of Two Doses of Empagliflozin (BI 10773) (Once Daily Versus Twice Daily) in Patients With Type 2 Diabetes Mellitus and Preexisting Metformin Therapy

Safety, Tolerability and Pharmacokinetics of Single Dose Intravenous Moxifloxacin in Pediatric Patients

A Study to Compare Tenofovir DF Versus the Combination of Emtricitabine Plus Tenofovir DF for the Treatment of Chronic Hepatitis B in Patients With Normal Alanine Aminotransferase (ALT)

A Safety and Efficacy Study of Dexmedetomidine in Patients Requiring Sedation for Elective Awake Fiberoptic Intubation

A Retrospective Chart Review of Patients Treated With Ocriplasmin for Symptomatic VMA

BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)

VST-1001 (Dilute Fluorescein) for Lymphatic Mapping & Localization of Lymph Nodes in Patients With Breast Cancer

A Phase II Clinical Trial of PXD101 in Patients With Recurrent or Refractory Cutaneous and Peripheral T-Cell Lymphomas

Spine Patient Outcomes Research Trial (SPORT) - Intervertebral Disc Herniation

Combination of GTI-2040 and Cytarabine in the Treatment of Refractory and Relapsed Acute Myeloid Leukemia (AML)

Safety and Efficacy of Merlin (Ethanol and Glycolic Acid Mixture) for the Treatment of Cold Sores

Follow-up Study After 11 Years of Patients Who Were Included in the BENEFIT Trial (304747) With a First Demyelinating Event Suggestive of Multiple Sclerosis